Company Overview
Snapshot
Founded in April 2018 by Amir Beker, BSP Medical operates with 1–10 employees. The company has secured one funding round from one investor, focusing on developing noninvasive solutions for diagnosing cardiac diseases.
Business overview
BSP Medical is a biomedical technology company specializing in noninvasive solutions for diagnosing cardiac diseases within the Health Tech & Life Sciences sector. The company offers a range of electrocardiogram (ECG) products based on its proprietary HyperQ technology, including complete systems for routine clinical use, research-oriented systems, and OEM products. Its HyperQ Analyzer Stress and HyperQ Analyzer Rest software modules are designed to analyze stress-test ECGs and facilitate the early detection of acute coronary artery disease on resting ECG systems, serving healthcare providers, hospitals, and clinics globally, in Israel, and China.
Log in to access full profile ›Company Intelligence Q&A
- What is BSP Medical's core focus?
- BSP Medical focuses on developing noninvasive solutions for the diagnosis of cardiac diseases, utilizing its HyperQ technology for electrocardiogram (ECG) products.
- Who founded BSP Medical?
- BSP Medical was founded by Amir Beker in April 2018.
- What is HyperQ Analyzer Stress?
- HyperQ Analyzer Stress is a software module developed by BSP Medical designed to analyze stress-test ECGs by detecting changes in the high-frequency component of the QRS segment. It can be integrated into existing ECG stress systems or applied to big data.
- What is HyperQ Analyzer Rest?
- HyperQ Analyzer Rest is a software module from BSP Medical for the early detection of acute coronary artery disease on resting ECG systems, aiding in the diagnosis of non-ST-elevation myocardial infarction and unstable angina.
- What markets does BSP Medical serve?
- BSP Medical serves global markets, with a specific focus on Israel and China, providing its cardiac diagnostic solutions to healthcare providers, hospitals, and clinics.